InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the fiscal year ended June 30, 2022. Conference Call […]

Relief Reports Half-Year 2022 Results and Provides Corporate Update

GENEVA, SWITZERLAND / ACCESSWIRE / September 15, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Relief”), a Swiss, commercial-stage biopharmaceutical company seeking to provide patients therapeutic benefit from selected specialty, rare and ultra-rare diseases with high unmet need, today reported its results for the half-year ended June 30, 2022 and provided […]

Aequus Reports 2nd Quarter 2022 Economic Highlights and Standard Update

Aequus Prescription drugs VANCOUVER, British Columbia, Aug. 29, 2022 (World NEWSWIRE) — Aequus Prescription drugs Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical enterprise with a concentration on establishing, advancing, and advertising and marketing differentiated goods, has employed Rabin Ramanjooloo as Director of Functions and nowadays […]

Discovery Reports Q2 2022 Financial Results and Update

Discovery Silver Corp. TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX-V: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce its financial results for the three months ended June 30, 2022 (“Q2 2022”) and provide a summary of key events for the quarter, and subsequent […]

Subscribe US Now